Hepatocyte Growth Factor

  • Donald P. Bottaro
  • Vittoria Cioce
  • Andrew M.-L. Chan
  • David H. Adams
  • Jeffrey S. Rubin
Part of the Serono Symposia USA Norwell, Massachusetts book series (SERONOSYMP)


Hepatocyte growth factor (HGF) was originally detected in the circulation of hepatectomized animals on the basis of its ability to stimulate hepatocyte proliferation in another animal with an intact liver (1–3). It was purified from serum, plasma, or blood platelets in the form of a disulfide-linked heterodimer of ~ 60-kd heavy (alpha) and ~ 32-kd light (beta) polypeptide chains (1–3). HGF was independently isolated from the conditioned medium of cultured fibroblasts based on its mitogenic activity on a variety of cellular targets (4), or its ability to stimulate the dispersion of epithelial and vascular endothelial cells (5–7). These sources yielded a ~90-kd monomeric polypeptide that copurified with the aforementioned heterodimer (4–6). Analysis of these polypeptides and subsequent molecular cloning and recombinant expression of HGF revealed that it was synthesized and secreted in the monomeric ~90-kd form (4), and proteolytically converted to the disulfide-linked heterodimer. Several laboratories have shown that proteolytic conversion of the monomeric precursor to the heterodimer, which can occur in situ, is required for biologic activity (8–10). The strong affinity of HGF for heparin was exploited as a major enrichment step in many of the purification schemes (1–6, 11), and the interaction between HGF and this ubiquitous extracellular matrix component may play an important role in HGF sequestration and signaling, as has been demonstrated for members of the fibroblast growth factor family (reviewed in 12).


Hepatocyte Growth Factor Scatter Factor Mitogenic Activity Kringle Domain Fibroblast Growth Factor Family 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 1987;224:311–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Gohda E, Tsubouchi H, Nakayama H, et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988;81:414–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Zarnegar R, Michalopoulos G. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res 1989;49:3314–20.PubMedGoogle Scholar
  4. 4.
    Rubin JS, Chan AM, Bottaro DP, et al. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci USA 1991;88:415–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Gherardi E, Gray J, Stoker M, Perryman M, Furlong R. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc Natl Acad Sci USA 1989;86:5844–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Weidner KM, Behrens J, Vandekerckhove J, Birchmeier W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol 1990;111:2097–108.PubMedCrossRefGoogle Scholar
  7. 7.
    Rosen EM, Meromsky L, Goldberg I, Bhargava M, Setter E. Studies on the mechanism of scatter factor. Effects of agents that modulate intracellular signal transduction, macromolecular synthesis and cytoskeleton assembly. J Cell Sci 1990;96:639–49.PubMedGoogle Scholar
  8. 8.
    Naka D, Ishii T, Yoshiyama Y, et al. Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer. J Biol Chem 1992;267:20114–9.PubMedGoogle Scholar
  9. 9.
    Gak E, Taylor WG, Chan AM, Rubin JS. Processing of hepatocyte growth factor to the heterodimeric form is required for biological activity. FEBS Lett 1992;311:17–21.PubMedCrossRefGoogle Scholar
  10. 10.
    Naldini L, Tamagnone L, Vigna E, et al. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 1992;11:4825–33.PubMedGoogle Scholar
  11. 11.
    Rosen EM, Goldberg ID, Kacinski BM, Buckholz T, Vinter DM. Smooth muscle releases an epithelial cell scatter factor which binds to heparin. In Vitro Cell Dev Biol 1989;25:163–73.PubMedCrossRefGoogle Scholar
  12. 12.
    Rapraeger AC, Giumond S, Krufka A, Olwin BB. Regulation by heparan sulfate in fibroblast growth factor signaling. Methods Enzymol 1994;245:219–40.PubMedCrossRefGoogle Scholar
  13. 13.
    Miyazawa K, Tsubouchi H, Naka D, et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 1989;163:967–73.PubMedCrossRefGoogle Scholar
  14. 14.
    Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989;342:440–3.PubMedCrossRefGoogle Scholar
  15. 15.
    Weidner KM, Arakaki N, Hartmann G, et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 1991;88:7001–5.PubMedCrossRefGoogle Scholar
  16. 16.
    Joplin R, Hishida T, Tsubouchi H, et al Human intrahepatic biliary epithelial cells proliferate in vitro in response to human hepatocyte growth factor. J Clin Invest 1992;90:1284–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Igawa T, Kanda S, Kanetake H, et al. Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cells. Biochem Biophys Res Commun 1991;174:831–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Halaban R, Rubin JS, Funasaka Y, et al. Met and hepatocyte growth factor/ scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene 1992;7:2195–206.PubMedGoogle Scholar
  19. 19.
    Kmiecik TE, Keller JR, Rosen E, Vande Woude GF. Hepatocyte growth factor is a synergistic factor for the growth of hematopoietic progenitor cells. Blood 1992;80:2454–7.PubMedGoogle Scholar
  20. 20.
    Shima N, Itagaki Y, Nagao M, Yasuda H, Morinaga T, Higashio K. A fibroblast-derived tumor cytotoxic factor/F-TCF (hepatocyte growth factor/ HGF) has multiple functions in vitro. Cell Biol Int Rep 1991;15:397–408.PubMedCrossRefGoogle Scholar
  21. 21.
    Stoker M, Perryman M. An epithelial scatter factor released by embryo fibroblasts. J Cell Sci 1985;77:209–23.PubMedGoogle Scholar
  22. 22.
    Montesano R, Schaller G, Orci L. Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors. Cell 1991;66:697–711.PubMedCrossRefGoogle Scholar
  23. 23.
    Tsarfaty I, Resau JH, Rulong S, Keydar I, Faletto DL, Vande Woude GF. The met proto-oncogene receptor and lumen formation. Science 1992;257:1258–61.PubMedCrossRefGoogle Scholar
  24. 24.
    Bussolino F, Di Renzo MF, Ziche M, et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992;119:629–41.PubMedCrossRefGoogle Scholar
  25. 25.
    Grant DS, Kleinman HK, Goldberg ID, et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 1993;90:1937–41.PubMedCrossRefGoogle Scholar
  26. 26.
    Rosen EM, Nigam SK, Goldberg ID. Scatter Factor and the c-Met receptor: a paradigm for mesenchymal/epithelial interaction. J Cell Biol 1994;127:1783–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Thiery JP, Duband JL, Tucker GC. Cell migration in the vertebrate embryo: role of cell adhesion and tissue environment in pattern formation. Annu Rev Cell Biol 1985;1:91–113.PubMedCrossRefGoogle Scholar
  28. 28.
    Schmidt C, Bladt F, Goedecke S, et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995;373:699–702.PubMedCrossRefGoogle Scholar
  29. 29.
    Uehara Y, Minowa O, Mori C, et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 1995;373:702–5.PubMedCrossRefGoogle Scholar
  30. 30.
    Rong S, Bodescot M, Blair D, et al. Tumorigenicity of themet proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol 1992;12:5152–8.PubMedGoogle Scholar
  31. 31.
    Rosen EM, Knesel J, Goldberg ID, et al. Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int J Cancer 1994;57:706–14.PubMedCrossRefGoogle Scholar
  32. 32.
    Yamashita J, Ogawa M, Yamashita S, et al. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 1994;54:1630–3.PubMedGoogle Scholar
  33. 33.
    Seslar MA, Nakamura T, Byers SW. Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors. Cancer Res 1993;53:1233–8.PubMedGoogle Scholar
  34. 34.
    Tajima H, Matsumoto K, Nakamura T. Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species. Exp Cell Res 1992;202:423–31.PubMedCrossRefGoogle Scholar
  35. 35.
    Shibamoto S, Hayakawa M, Hon T, et al. Hepatocyte growth factor and transforming growth factor-beta stimulate both cell growth and migration of human gastric adenocarcinoma cells. Cell Struct Funct 1992;17:185–90.PubMedCrossRefGoogle Scholar
  36. 36.
    Shiota G, Rhoads DB, Wang TC, Nakamura T, Schmidt EV. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci USA 1992;89:373–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Delaney B, Koh WS, Yang KH, Strom SC, Kaminski NE. Hepatocyte growth factor enhances B-cell activity. Life Sci 1993;53:PL89–93.PubMedCrossRefGoogle Scholar
  38. 38.
    Takebayashi T, Iwamoto M, Jikko A, et al. Hepatocyte growth factor/scatter factor modulates cell motility, proliferation, and proteoglycan synthesis of chondrocytes. J Cell Biol 1995;129:1411–9.PubMedCrossRefGoogle Scholar
  39. 39.
    Adams DH, Harvath L, Bottaro DP, et al. Hepatocyte growth factor and macrophage inflammatory protein 1B: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-perferential migration in T-cells. Proc Natl Acad Sci USA 1994;91:7144–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Seki T, Ihara I, Sugimura A, et al. Isolation and expression of cDNA for different forms of hepatocyte growth factor from human leukocyte. Biochem Biophys Res Commun 1990;172:321–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Jiang W, Puntis MC, Nakamura T, Hallett MB. Neutrophil priming by hepatocyte growth factor, a novel cytokine. Immunology 1992;77:147–9.PubMedGoogle Scholar
  42. 42.
    Wolf HK, Zarnegar R, Michalopoulos GK. Localization of hepatocyte growth factor in human and rat tissues: an immunohistochemical study. Hepatology 1991;14:488–94.PubMedCrossRefGoogle Scholar
  43. 43.
    Naka D, Ishii T, Shimomura T, Hishida T, Hara H. Heparin modulates the receptor-binding and mitogenic activity of hepatocyte growth factor on hepatocytes. Exp Cell Res 1993;209:317–24.PubMedCrossRefGoogle Scholar
  44. 44.
    Arakaki N, Hirono S, Ishii T, et al. Identification and partial characterization of two classes of receptors for human hepatocyte growth factor on adult rat hepatocytes in primary culture. J Biol Chem 1992;267:7101–7.PubMedGoogle Scholar
  45. 45.
    Zioncheck TF, Richardson L, Liu J, et al. Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity. J Biol Chem 1995;270:16871–8.PubMedCrossRefGoogle Scholar
  46. 46.
    Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251:802–4.PubMedCrossRefGoogle Scholar
  47. 47.
    Weidner KM, Sachs M, Birchmeier W. The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/ hepatocyte growth factor in epithelial cells. J Cell Biol 1993;121:145–54.PubMedCrossRefGoogle Scholar
  48. 48.
    Cooper CS, Park M, Blair DG, et al. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 1984;311:29–33.PubMedCrossRefGoogle Scholar
  49. 49.
    Park M, Dean M, Cooper CS, et al. Mechanism of met oncogene activation. Cell 1986;45:895–904.PubMedCrossRefGoogle Scholar
  50. 50.
    Park M, Dean M, Kaul K, Braun MJ, Gonda MA, Vande Woude G. Sequence of MET prot000ncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc Natl Acad Sci USA 1987;84:6379–83.PubMedCrossRefGoogle Scholar
  51. 51.
    Giordano S, Di Renzo MF, Narsimhan RP, Cooper CS, Rosa C, Comoglio PM. Biosynthesis of the protein encoded by the c-met proto-oncogene. Oncogene 1989;4:1383–8.PubMedGoogle Scholar
  52. 52.
    Ferracini R, Longati P, Naldini L, Vigna E, Comoglio PM. Identification of the major autophosphorylation site of the Met/hepatocyte growth factor receptor tyrosine kianse. J Biol Chem 1991;266:19558–64.PubMedGoogle Scholar
  53. 53.
    Rubin JS, Bottaro DP, Aaronson SA. Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim Biophys Acta 1993;1155:357–71.PubMedGoogle Scholar
  54. 54.
    Hayman MJ, Kitchener G, Vogt PK, Beug H. The putative transforming protein of S13 avian erythroblastosis virus is a transmembrane glycoprotein with an associated protein kinase activity. Proc Natl Acad Sci USA 1985;82:8237–41.PubMedCrossRefGoogle Scholar
  55. 55.
    Huff JL, Jelinek MA, Borgman CA, Lansing TJ, Parsons JT. The protooncogene c-sea encodes a transmembrane protein-tyrosine kinase related to the Met/hepatocyte growth factor/scatter factor receptor. Proc Natl Acad Sci USA 1993;90:6140–4.PubMedCrossRefGoogle Scholar
  56. 56.
    Skeel A, Yoshimura T, Showalter SD, Tanaka S, Appella E, Leonard EJ. Macrophage stimulating protein: purification, partial amino acid sequence, and cellular activity. J Exp Med 1991;173:1227–34.PubMedCrossRefGoogle Scholar
  57. 57.
    Furlong RA, Takehara T, Taylor WG, Nakamura T, Rubin JS. Comparison of biological and immunochemical properties indicates that scatter factor and hepatocyte growth factor are indistinguishable. J Cell Sci 1991;100:173–7.PubMedGoogle Scholar
  58. 58.
    Chan AM, Rubin JS, Bottaro DP, Hirschfield DW, Chedid M, Aaronson SA. Identification of a competitive HGF antagonist encoded by an alternative transcript. Science 1991;254:1382–5.PubMedCrossRefGoogle Scholar
  59. 59.
    Hartmann G, Naldini L, Weidner KM, et al. A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis. Proc Natl Acad Sci USA 1992;89:11574–8.PubMedCrossRefGoogle Scholar
  60. 60.
    Yu YL, Kha H, Golden JA, Migchielsen AA, Goetzl EJ, Turck CW. An acidic fibroblast growth factor protein generated by alternate splicing acts like an anatogonist. J Exp Med 1992;175:1073–80.PubMedCrossRefGoogle Scholar
  61. 61.
    Cioce V, Casky KG, Chan AM-L, et al. HGF/NK1 is a naturally occurring HGF/SF variant with partial agonist/antagonist activity. J Biol Chem 1996; in press.Google Scholar
  62. 62.
    Han S, Stuart LA, Degen SJ. Characterization of the DNF15S2 locus on human chromosome 3: identification of a gene coding for four kringle domains with homology to hepatocyte growth factor. Biochemistry 1991;30:9768–80.PubMedCrossRefGoogle Scholar
  63. 63.
    Gaudino G, Follenzi A, Naldini L, et al. Ron is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J 1994;13:3524–32.PubMedGoogle Scholar
  64. 64.
    Wang M-H, Skeel A, Leonard EJ, et al. Identification of the Ron gene product as the receptor for the human macrophage stimulating protein. Science 1994; 266:117–9.PubMedCrossRefGoogle Scholar
  65. 65.
    Ronsin C, Muscatelli F, Mattei MG, Breathnach R. A novel putative receptor protein tyrosine kinase of the met family. Oncogene 1993;8:1195–202.PubMedGoogle Scholar
  66. 66.
    Smith DR, Vogt PK, Hayman MJ. The v-sea oncogene of avian erythroblastosis retrovirus S13: another member of the protein-tyrosine kinase gene family. Proc Natl Acad Sci USA 1989;86:5291–5.PubMedCrossRefGoogle Scholar
  67. 67.
    Tsubouchi H, Kawakami S, Hirono S, et al. Prediction of outcome in fulminant hepatic failure by serum human hepatocyte growth factor [letter]. Lancet 1992;340:307.PubMedCrossRefGoogle Scholar
  68. 68.
    Okajima A, Miyazawa K, Kitamura N. Primary structure of rat hepatocyte growth factor and induction of its mRNA during liver regeneration following hepatic injury. Eur J Biochem 1990;193:375–81.PubMedCrossRefGoogle Scholar
  69. 69.
    Zarnegar R, Defrances MC, Kost DP, Lindroos P, Michalopoulos GK. Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem Biophys Res Commun 1991;177:559–65.PubMedCrossRefGoogle Scholar
  70. 70.
    Tsubouchi H, Niitani Y, Hirono S, et al. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 1991;13:1–5.PubMedCrossRefGoogle Scholar
  71. 71.
    Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1992;16:1227–35.PubMedGoogle Scholar
  72. 72.
    Nagaike M, Hirao S, Tajima H, et al. Renotropic functions of hepatocyte growth factor in renal regeneration after unilateral nephrectomy. J Biol Chem 1991;266:22781–4.PubMedGoogle Scholar
  73. 73.
    Di Renzo MF, Olivero M, Ferro S, et ai. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 1992;7:2549–53.PubMedGoogle Scholar
  74. 74.
    Kuniyasu H, Yasui W, Kitadai Y, Yokozaki H, Ito H, Tahara E. Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun 1992;189:227–32.PubMedCrossRefGoogle Scholar
  75. 75.
    Soman NR, Correa P, Ruiz BA, Wogan GN. The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proc Natl Acad Sci USA 1991;88:4892–6.PubMedCrossRefGoogle Scholar
  76. 76.
    Uehara Y, Kitamura N. Expression of a human hepatocyte growth factor/ scatter factor cDNA in MDCK epithelial cells influences cell morphology, motility, and anchorage-independent growth. J Cell Biol 1992;117:889–94.PubMedCrossRefGoogle Scholar
  77. 77.
    Tsarfaty I, Rong S, Resau JH, et al. Met mediated signaling in mesenchymal to epithelial cell conversion. Science 1994;263:98–101.PubMedCrossRefGoogle Scholar
  78. 78.
    Jeffers M, Rong S, Vande Woude GF. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-Met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 1996;16:1115–25.PubMedGoogle Scholar
  79. 79.
    Kenworthy P, Dowrick P, Baillie-Johnson H, et al. The presence of scatter factor in patients with metastatic spread to the pleura. Br J Cancer 1992; 66:243–47.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Donald P. Bottaro
  • Vittoria Cioce
  • Andrew M.-L. Chan
  • David H. Adams
  • Jeffrey S. Rubin

There are no affiliations available

Personalised recommendations